TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
MXCT

MaxCyte Inc

Healthcare · Medical Devices

1.20$ -0.4% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Balance Sheet

MaxCyte Inc (MXCT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 185 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet MXCT
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
267 268 258 251 249 239 230 220 213 203 194 185
214 190 179 176 173 172 156 143 125 118 123 121
49 47 22 38 37 28 23 15 13 20 15 15
190 168 158 157 154 154 138 127 106 103 15 106
8.2 5.8 6.0 4.6 4.6 4.7 5.5 5.8 8.3 3.5 4.2 3.9
13 12 12 11 10 8.9 8.3 7.9 7.6 7.5 7.6 7.8
3.9 3.7 3.6
0.5 0.6 0.7 0.7 0.8 0.8
33 36 32 30 35 33 31 29 33 31 27 26
17 18 13 12 18 16 13 12 16 14 10 9.9
0.7 0.8 0.8 0.9 0.9 0.9 1.3 1.3 1.3 1.5 1.4 1.5
0.4 0.7 1.7 1.0 1.9 1.4 2.3 1.2 1.3 1.4 1.2 1.7
233 232 226 221 213 206 199 191 180 171 168 159
-171 -176 -185 -195 -206 -217 -227 -239 -252 -261 -266 -275
103 104 104 105 105 105 106 106 106 106 107 107

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?